Advancements in Gastroenterology and Future Insinuations in Digestive Disorders!
GASTROENTEROLOGY 2018 welcomes Students, Doctors, Physicians, leading universities and research institutions, presenters, and exhibitors from all over the world to Melbourne, Australia. We are delighted to invite you all to attend and register for the „International Conference on Gastroenterology & Digestive Disorders” which is going to be held during May 14-16, 2018 at Melbourne, Australia by Cenetri Publishing Group. We cordially invite you to join us at the Gastroenterology 2018, where you will be sure to have a meaningful experience with scholars around the world. All the members of Gastroenterology 2018, organizing committee look forward to meet you in Melbourne.
Gastroenterology is the study of the normal function and diseases of the esophagus, stomach, small intestine, colon and rectum, pancreas, gallbladder, bile ducts and liver. It involves a detailed understanding of the normal action (physiology) of the gastrointestinal organs including the movement of material through the stomach and intestine (motility), the digestion and absorption of nutrients into the body, removal of waste from the system, and the function of the liver as a digestive organ. It includes common and important conditions such as colon polyps and cancer, hepatitis, Gastroesophageal reflux (heartburn), peptic ulcer disease, colitis, gallbladder and biliary tract disease, nutritional problems, Irritable Bowel Syndrome (IBS), and pancreatitis. In essence, all normal activity and disease of the digestive organs are part of the study of Gastroenterology.
Scope and Importance
Ten years from now the practice of gastroenterology will have a very different look and feel. Many doctors are trying to keep up with the pace of change in the structure of practices. Realignments and the decline of office-based private practice have been rapid and dramatic. We live in an era of health system empowerment and many physicians are struggling to adjust. Technological and therapeutic advances will also alter the landscape. Change in workflow, increase reliance on ancillary personnel such as physician assistants and medical assistants increase in scope as gastroenterologists devote more of their time to the procedure/technical based aspects of the specialty.
Bowel Disease rates are increasing in Australia
Bowel cancer is the most common internal cancer in Australian community with mortality second only to lung cancer. Activities with gastroenterologists, colorectal surgeons and epidemiologists have found that it affects about 1 in 20 people today. These findings set the stage to encourage the prevention or early diagnosis by using screening tests and continued surveillance of those in high risk groups. Your doctor can tell you if you are in such a group.
Gastrointestinal Disorder Statistics:
- Irritable bowel syndrome (IBS) is the most common functional gastrointestinal (GI) disorder with worldwide prevalence rates ranging generally in the area of 10–15%.
- Among patients about 40% of people have mild IBS, 35% moderate IBS, and 25% severe IBS. Many people don’t recognize IBS symptoms. Yet, IBS is one of the most common disorders seen by physicians.
- Not all individuals with IBS symptoms seek medical care for their symptoms. IBS is the most common disorder diagnosed by gastroenterologists (doctors who specialize in digestive diseases or disorders) and accounts for up to 12% of total visits to primary care providers.
- The cost to society in terms of direct medical expenses & indirect costs associated with loss of productivity and work absenteeism is considerable, estimates range from $21 billion or more annually.
- Significant proportions, 35%-40% of individuals who report IBS in the community are male. Approx.60% to 65% of individuals who report IBS in the community is female.
- IBS is a major women’s health issue. Data reveals an increased risk of unnecessary surgery for extra-abdominal and abdominal surgery in IBS patients. For example, hysterectomy or ovarian surgery has been reported in female patients with IBS as high as 47% to 55% and has been performed more often in the IBS patient than in comparison groups.